| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Short Communications |
1 Baylor College of Medicine, Department of Family and Community Medicine, Houston, Texas; 2 Center for Health Promotion and Prevention Research, University of TexasHouston School of Public Health, Houston, Texas; 3 Division of Cancer Prevention, University of Texas M. D. Anderson Cancer Center, Houston, Texas; and 4 University of TexasHouston School of Public Health, formerly of Kelsey Research Foundation, Houston, Texas
The primary objective of this study was to determine the prevalence of colorectal cancer (CRC) screening among eligible patients in a large medical practice. A secondary objective was to compare CRC screening rates obtained from medical records with physician self-reported CRC screening recommendation. We conducted a retrospective record review of 214 patients ages
50 years of a large multispecialty medical organization in Houston, Texas, for receipt of fecal occult blood test (FOBT), flexible sigmoidoscopy (SIG), and/or colonoscopy (COL). We estimated prevalence using two definitions: (a) FOBT in past year or SIG in past 5 years or COL in past 10 years; and (b) FOBT in past year and SIG in past 5 years or COL in past 10 years. Age, gender, race/ethnicity, family history, number of chronic conditions, and index visit were independent variables. Contingency table and logistic regression analysis were used to test for associations between outcomes and independent variables. Our study population was 48% male with a mean age of 63 years (range: 5384 years). One-quarter of the records showed FOBT by 3-day kit (51 of 214) and 27% by digital rectal exam (57 of 214). SIG was recorded in 32% of records. Half (54%) of the records had documentation of CRC screening according to definition no. 1 and 19% according to definition no. 2. Screening rates from medical record review were lower than those derived from physician self-report. Our findings underscore the need for interventions to improve CRC screening in primary care settings.
This article has been cited by other articles:
![]() |
L. E. Lamerato, P. M. Marcus, G. Jacobsen, and C. C. Johnson Recruitment in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial: the First Phase of Recruitment at Henry Ford Health System Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 827 - 833. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Vernon, J. A. Tiro, R. W. Vojvodic, S. Coan, P. M. Diamond, A. Greisinger, and M. E. Fernandez Reliability and Validity of a Questionnaire to Measure Colorectal Cancer Screening Behaviors: Does Mode of Survey Administration Matter? Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 758 - 767. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Schenck, C. N. Klabunde, J. L. Warren, S. Peacock, W. W. Davis, S. T. Hawley, M. Pignone, and D. F. Ransohoff Data Sources for Measuring Colorectal Endoscopy Use Among Medicare Enrollees Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 2118 - 2127. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Fenton, Y. Cai, N. S. Weiss, J. G. Elmore, R. E. Pardee, R. J. Reid, and L.-M. Baldwin Delivery of Cancer Screening: How Important Is the Preventive Health Examination? Arch Intern Med, March 26, 2007; 167(6): 580 - 585. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |